Gyre Therapeutics (GYRE) Short-term Investments (2010 - 2026)
Gyre Therapeutics (GYRE) posted Short-term Investments of $14.1 million for Q2 2026, down 21.2% from $17.9 million a year earlier but up 14.6% from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) Short-term Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Gyre Therapeutics' Short-term Investments came in at $15.4 million, up 3.4% from FY2024.
- Annual Short-term Investments shows a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- In prior years, Gyre Therapeutics' Short-term Investments was $14.9 million in FY2024, -$3.48 million in FY2022 and $2.5 million in FY2021 (-94.9%).
- Quarterly Short-term Investments has run from a low of -$3.48 million in Q4 2022 to a high of $19.65 million in Q3 2025 over five years.
- On a year-over-year basis, Short-term Investments increased in four of the last six quarters, with growth averaging 45.4%.
- The strongest year-over-year quarter for Short-term Investments in the past five years was Q3 2025, with growth of 113.0%; the weakest was Q4 2021, with a decline of 94.9%.
- According to Business Quant data, Short-term Investments for the three prior quarters was $12.31 million (Q1 2026), $15.4 million (Q4 2025) and $19.65 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Gyre Therapeutics | 753.90 Mn | 556.61 Mn | 26.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.10 Mn |
| Mar 31, 2026 | 12.31 Mn |
| Dec 31, 2025 | 15.40 Mn |
| Sep 30, 2025 | 19.65 Mn |
| Jun 30, 2025 | 17.90 Mn |
| Mar 31, 2025 | 14.85 Mn |
| Dec 31, 2024 | 14.90 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 9.00 Mn |
| Mar 31, 2024 | 7.60 Mn |
| Dec 31, 2022 | -3.48 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 5.37 Mn |
| Jun 30, 2021 | 12.90 Mn |
| Mar 31, 2021 | 23.96 Mn |
| Dec 31, 2020 | 48.99 Mn |
| Sep 30, 2020 | 77.96 Mn |
| Jun 30, 2020 | 58.09 Mn |
| Mar 31, 2020 | 34.16 Mn |
| Dec 31, 2019 | 61.50 Mn |
API Access
Gyre Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();